Pyrimethamine (PY), an inhibitor of folate reductase, blocks mitochondrial protein synthesis in yeast, presumably by creating a shortage of formylmethionyltRNA. This has been established by measuring in intact cells the effect of the drug on the formation of cytochromes a-a, and b, and on the incorporation of labelled leucine when cytoplasmic protein synthesis is suppressed by cycloheximide. As a result, growth of the organism in non-fermentable (glycerol) medium is arrested by relatively low concentrations of PY, which have little effect in fermentable (dextrose) medium where respiratory activity is not essential. However, higher drug concentrations do inhibit growth in dextrose medium, probably by preventing thymine synthesis. Under some conditions the budding process is modified, giving rise to abnormal elongated cells. The inhibitory effect of PY is prevented by exogenous tetrahydrofolate.
Pyrimethamine (PY), an inhibitor of folate reductase, blocks mitochondrial protein synthesis in yeast, presumably by creating a shortage of formylmethionyltRNA. This has been established by measuring in intact cells the effect of the drug on the formation of cytochromes a-a, and b, and on the incorporation of labelled leucine when cytoplasmic protein synthesis is suppressed by cycloheximide. As a result, growth of the organism in non-fermentable (glycerol) medium is arrested by relatively low concentrations of PY, which have little effect in fermentable (dextrose) medium where respiratory activity is not essential. However, higher drug concentrations do inhibit growth in dextrose medium, probably by preventing thymine synthesis. Under some conditions the budding process is modified, giving rise to abnormal elongated cells. The inhibitory effect of PY is prevented by exogenous tetrahydrofolate.
Prolonged exposure to low concentrations of the drug, or shorter exposure to higher concentrations, leads to an induction of mitochondrial petite mutants and cell death, presumably as a consequence of thymine starvation. Petite mutants are particularly susceptible to killing by PY. Those induced by the drug are of the suppressible type, and hence would appear to result from a modification to (rather than a loss of) the mitochondrial DNA.
I N T R O D U C T I O N
Folate analogues which inhibit folate reductase block the conversion of dihydrofolate to tetrahydrofolate (THFA) and so suppress all formylation reactions involving formyl-THFA. This affects the synthesis of glycine, methionine, purines, pantothenate and thymine. It also prevents the formylation of methionyl-tRNA,,,,,, which is essential for the initiation of polypeptide synthesis in bacteria and mitochondria but not, apparently, for protein synthesis in the cytoplasm of eukaryotes (Bianchetti, Lucchini & Sartirana, 1971 ; Rudland & Clark, I 972). Trimethoprim, a potent inhibitor of folate reductase in bacteria, is ineffective against our yeast strains. However, we have found that pyrimethamine (PY), commonly used as an antimalarial drug and now under test as an agent against leukaemia (Geils, Scott, Baugh & Butterworth, 1971) , is a useful inhibitor in this organism and is considerably more effective than methotrexate, another folate reductase inhibitor. The potency of PY may be a consequence of its high lipophilicity, allowing easier passage across the cell membrane.
The culture media used in the present work provide a readily assimilable source of amino acids, purines and pantothenate, so that the inhibition observed can only result from a shortage of thymine or a block in mitochondrial protein synthesis. In Saccharomyces cerevisiae these two aspects are distinguishable, since mitochondrial respiratory function is necessary only when the organism is growing on non-fermentable substrate (e.g. glycerol) and not when 284
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a fermentable sugar (e.g. dextrose) is provided. Thus preferential inhibition of mitochondria1 protein synthesis (necessary for the development of the respiratory chain) would arrest growth only in the former case.
M E T H O D S
Organisms. Sixteen haploid strains of Saccharomyces cerevisiae were used for initial screening purposes, of which three werc studied in more detail: s41 ( (Mortimer & Hawthorne, r969) , containing glycerol as carbon source, was supplemented with yeast extract (0.1 %), uracil (10 ,ug/ml) and histidine (10 ,ug/ml). Culture temperature was $30 "C. Measurement of inhibition of growth and isolation of resistant mutants was carried out as described in Wilkie (1972 Cytochrome absorption spectra. Cells from 200 ml cultures were washed twice with I % saline, suspended in distilled water and the absorbance measured at room temperature in the Unicam SP I 800 recording spectrophotometer.
Measurement of respiratory activity. Washed cells from 3 ml culture were resuspended at approximately ro6 cells/ml in sodium phosphate buffer (0.1 mM, pH 6.8) containing sodium succinate (0.5 mM). Oxygen uptake was measured polarographically in a Clark-type oxygen electrode coupled to a pen recorder.
Growth curves. Extinctions (corrected for non-linear response) were measured either with an E.E.L. colorimeter (Evans Electroselenium Ltd) using filter OGRi (Fig. I ) or with a Hilger colorimeter at 580 nm (Fig. 2) .
Protein synthesis &termination. Portions ( I ml) of cultures growing exponentially in supplemented MM (see above) were inoculated into glass centrifuge tubes containing 3 p g ~4 4 , 5-3H]leucine (30 Ci/mM) and shaken at 30 "C for 1.5 h, after which incorporation was stopped by the addition of 2 ml trichloroacetic acid (5 %, w/v Cultural conditions. Yeast extract ( I 7; Difco) medium was supplemented with 4 R E S U L T S
Inliibition bj7 P Y on solid media
Initial screening for drug activity against I 6 yeast strains was performed on agar plates containing non-fermentable Y EG or fermentable YED media. On YEG, all strains tested were totally inhibited in growth at a drug concentration of 700 ,ug/ml. At 250 /lg/ml, eight strains were inhibited, while roo pg/ml arrested the growth of two strains (~41 and 1118). On Efiects of pyrimethamine ill yeast 285 YED, on the other hand, 1000 /rgPY/ml inhibited all strains, and six strains were inhibited at 700pg/ml. On dextrose medium, 250pglrnl had no detectable effect on any of the strains. These results suggest that low concentrations of PY selectively suppress protein synthesis in the mitochondria. Inhibition of growth on YED medium at higher drug concentrations presumably results from thymine starvation, which would appear to require a more complete suppression of THFA synthesis.
Cytoplasmic petite mutants, in which there is no mitochondrial protein synthesis (see Borst, 1972) , were also inhibited by PY on YED medium and this is discussed in detail later.
Trimethoprim at a concentration of 1000 pg/ml had no effect on the growth of the I 6 strains on either YEG or YED medium. Methotrexate was inhibitory but was less potent than PY. Only half of the strains were inhibited at 1000 p g of this drug/ml on YEG medium, but some growth was possible by these strains at this concentration on YED medium. At a methotrexate concentration of 250 pg/ml, no inhibitory effect on growth was detectable on either medium.
Sulphanilamide and sulphathiazole, compounds which in bacteria inhibit folate biosynthesis (rather than folate reduction), had no apparent effect on growth of the yeast strains at concentrations up to 1000 ,ug/ml.
Inhibition 011 fernwritable substrates other than dextrose
Strains were also grown on solid medium with galactose or melibiose as the carbon source. In general, the cultures were more susceptible to inhibition by PY than they were on dextrose medium, but less so than on glycerol medium. Thus, a differential effect was still seen in comparing fermentable with non-fermentable medium when using fermentable sugars other than dextrose. However, the results suggest that some degree of mitochondrial function is necessary for the utilization of galactose and melibiose. This is supported by the finding that when mitochondria1 protein synthesis was arrested by the addition of 1000 p g erythromycin/ml, growth of all 16 strains was inhibited on YEG medium and of ten strains on medium containing galactose or melibiose. Since erythromycin is a specific inhibitor of mitochondrial protein synthesis (see Wilkie, 1970) , there was no inhibition on YED medium, as expected. Furthermore, two out of three cytoplasmic petite strains tested failed to grow on melibiose or galactose medium. It is possible that in some strains defects in the mitochondria, resulting either from the petite (p-) mutation or from the inhibitory effects of drugs, limit the uptake of melibiose and galactose by the cells. The observation that growth in YED medium in the presence of PY (100 pg/ml) greatly reduces the flocculent character of strain B~I also implicates a change at the cell surface. An apparently similar situation is described by Linstead, Evans & Wilkie (1974) , in which the cell binding of the lipophilic drug imipramine is frequently altered on conversion of yeast strains to the petite condition.
Eflect of P Y on growtli rate
was the most sensitive strain on solid medium it was studied in more detail. Growth curves obtained with various concentrations of the drug are shown in Fig. I . This again illustrates the greater sensitivity of the organism in non-fermentable medium.
When THFA (~ooo/ig/ml) was added to the drug medium, the inhibitory effect was prevented and growth proceeded more or less normally (Fig. 2) . This indicates that folate reductase is the only significant site at which PY acts, and excludes the possibility of the drug acting as an uncoupler of oxidative phosphorylation or interfering with the metabolism of other pteridine compounds. Eflkct qf P Y on ccll riiorpl~ology PY/ml, normal budding of the yeast was suppressed. After about 16 h incubation, individual cells gave rise to small clumps of elongated cells (Fig. 3a, b) . After staining with Giemsa, it was apparent that all cells possessed a nucleus and that many were binucleate. On incubation in drug-free YEG, each elongated cell proceeded to bud (Fig. 3 c) . When elongated cells were isolated by micromanipulation onto drug-free YEG and YED agar media, they recovered inasmuch as they produced normal p' buds after 2 to 4 h. The parent cells retained their elongated form, however.
If THFA (1000 pg/ml) was present in the YEG medium containing IOO ,ug PY/ml, no cell elongation occurred .
Cells of s41 neither budded nor elongated on YEG medium containing a higher con- centration of PY (500 pg/ml). In YED medium, PY did not affect the shape of s41 cells at any concentration tested (50 to 1000 pglml). Cells of strain D T~ behaved somewhat differently from those of s41. In YEG containing ~o o p g PY/ml, cell volume increased 10 to 20-fold with only slight elongation.
The fact that elongated cells were able to produce normal buds on transfer to drug-free medium, both YEG and YED, indicated that any abnormalities in the mitochondria or in the nucIei were reversible and that only the shape of the cell envelope was permanently altered. The basis of the phenomenon is not clear. It is not due to blockage of the mitochondrial system alone, since erythromycin failed to induce elongated forms of s4r. Nor can a shortage of thymine alone explain elongation, as no such effect was observed on Y E D medium at any concentration of PY.
It is of interest that daunomycin, which preferentially inhibits mitochondrial RNA synthesis in S. corevisiue (Evans, Linstead, Rhodes & Wilkie, I973), also produces elongated cells, as does tannic acid, a potent inhibitor of mitochondrial function in this organism (D. Linstead and D. Wilkie, unpublished observations).
Inhibition of respiratory activity, loss of viabifity and induction of t/w petitc mutation by P Y
The background frequency of p -cells is about 5 % in strain B~I and 2 % in D I~. These frequencies were increased significantly in the presence of PY on either carbon source, but only at high concentrations of the dru:; or long exposure to low concentrations. That is, petite mutants appeared under conditions which had a pronounced lethal effect (Table I) . Petite induction was always accompanied by impaired oxygen uptake in the treated culture, although, on the other hand, reduced respiratory activity was not always accompanied either by killing or the appearance of p-cells (Table I) . That there was indeed induction of petites, rather than selection by PY, was substantiated by testing the PY sensitivity of both spontaneous and 'PY-induced' p -strains derived from ~4 1 . These mutants were found to be no more resistant than the parent strain. On the contrary, the p-strains were more sensitive to the drug. Using spot inocula (Wilkie, 972) on to YED agar, growth of all petite strains tested was seriously inhibited at a cowentration of 100pg PY/ml and totally arrested at 300 pg/ml. Growth of the p+ parent strain was only slightly affected at 300 pg/ml, and 600 ,ug/ml was required for total inhibition.
Since there is no protein synthesis in petite mitochondria (see Borst, 1972) , inhibition of growth in the respiratory mutants is probably due to thymine deficiency. A further feature of petite strains was that they rapidly died when exposed to PY even at moderately low concentrations (Fig. 4) . These findings again point to the involvement of the mitochondria in the EfSects of pj,rimethnmine in yeast 289 specification of cell membrane components controlling permeability (cf. above, and , alterations which may permit a greater intracellular concentration of the drug.
Siippressivity o j P Y-induced petite straiiis
Eight p-strains were obtained from a ~4 1 culture which had been treated for 24 h with 1000 p g PY/ml in YED. Each of these was crossed with strain ~7 5 and individual diploids obtained. The frequencies of p-cells amongst the diploid cultures were I , I , 2, 3, 3, 8, 17 and 33 % respectively. These figures are significantly different from those obtained from the control cross of s41 by D75 (pi-x p+) , where the frequency of p-cells was about 0.2 in the derived diploid culture. Hence, PY produces suppressive petites, suggesting that they result from a modification of mitochondria1 DNA rather than the loss of this molecule, at least in the cases tested (see Borst, 1972) . P Y-resistant mutants A lawn of ~4 1 was spread on YEG plates containing ~o o p g PY/ml. After 48 h, several colonies developed against a background of inhibited cells. Thirteen of these spontaneous PY-resistant mutants were tested on YEG and YED plates containing PY at various concentrations (Table 2) , using very dilute inocula. On YEG, all were able to make substantial growth at 100 pg PY/ml; some were totally inhibited at 300 ,ug/ml, whereas others continued to grow at this higher concentration of the drug. On YED medium, all were more resistant than the parent strain, but again there was considerable variation in this respect. Some of these resistant mutants could have reduced permeability to the drug or the ability to detoxify it, and others a modified folate reductase. Further genetic and biochemical analyses will be required to establish these points.
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Idiibitiorz of synthesis of cytoclirornes a-a3 and b by P Y
The addition of PY up to a concentration of 600 ,ug/ml to cells of strain B 4 I in the oxygen electrode had no detectable effect on the oxygen uptake of these cells. This indicates that the inhibitory effect of PY on YEG medium does not result from a direct effect on the function of mitochondria, but presumably from interference with their biogenesis. Comparison of cytochrome spectra provides a useful means of assessing mitochondria1 protein synthesis in intact cells, since cytochrome c is made in the cytoplasm, whereas it is well established that the formation of cytochromes a-a, and t l requires protein synthesis in the mitochondria (cf. Wilkie, rg70). That PY prevents the synthesis of the latter cytochromes was apparent from a comparison of treated and untreated cells (Fig. 5) . In this series of experiments, anaerobically grown cells of strain 1341 were used in which cytochrome synthesis in general was severely suppressed (Fig. 5A) . When these cells were transferred to aerobic conditions in YEG Efects of pyrimethamine in yeast 29 I liquid medium supplemented with 0.2 dextrose, synthesis of all cytochrotnes occurred (Fig. 5 B) . When erythromycin (1000 pg/ml) was present during this period, only cytochrome c appeared (Fig. 5 C) . PY ( I 60 pg/mI) had a similar effect (Fig. 5 D) , except that the appearance of cytochromes a-u3 and b was not entirely prevented, presumably because of the cells' ability to draw on a pre-existing pool of formyl-THFA.
Inhibition of L3 HIIeucinc. incorporation into mitochondria by P Y
The view that PY inhibits mitochondria1 protein synthesis was confirmed by measuring incorporation of radioactive leucine by a culture of ~4 1 in which cytoplasmic protein synthesis was suppressed by cycloheximide. The cycloheximide-insensitive incorporation was significantly reduced when low concentrations of PY were present (Table 3) . Erythromycin had essentially the same effect.
Inhibition of Candida albicans by P Y
The sensitivity of S. cerevisiae to PY, and the fact that tolerance limits to PY in humans are well known, suggested that the drug may be potentially useful in the treatment of human mycosis. The drug was therefore tested against Candida albicans, a common human pathogen, for growth inhibition i n YEG medium and in a Casamino-acids (3 %, w/v) medium containing dextrose (0.2 %). In both of these media, growth of the organism was completely arrested by PY at a concentration of 500 ,ug/ml, and was 50 % inhibited at 250 ,ug/ml. The finding that sensitivity to the drug is independent of the carbon source is to be expected, since C. albicans is an obligate aerobe requiring functional mitochondria even for growth in dextrose medium. As serum levels of PY following administration of the drug are generally in the region of I to 1.5 ,ug/ml (Geils et al. 1971) , its usefulness in cases of Candida mycosis is doubtful.
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Our results support the view that the inhibition of yeast growth by high concentrations of PY is a consequence of thymine starvation. At lower concentrations, the main effect of the drug is to suppress protein synthesis in mitochondria, confirming that N-formylniethionine is indispensable for the initiation of mitochondrial proteins. Under the latter conditions, any available formyl groups are preferentially used for thymine synthesis. This is analogous to the situation in trimethoprim-inhi bited L~schcrichia coli, where, indeed, a standard technique for the isolation of thymineless mutants exploits the competition between DNA synthesis and protein synthesis for the small amount of formyl-THFA present (Stacey & Simson, At low concentrations of PY on glycerol medium, the inhibitory effects are initially reversible, as seen when the drug is removed from elongated cells. At high concentrations, or with continued exposure of the cells to low concentrations, there is an induction of the petite condition and a loss of viability. b e suggest that both these effects result from thymine starvation following more complete inhibition of THFA synthesis. Petite induction could result from a blockage of mitochondrial protein synthesis alone (Williamson, Maroudas & Wilkie, rg71), but in this respect it is significant that inhibition of mitochondrial protein synthesis by erythromycin, under the same experimental conditions as used for PY, had no eff'ect either on viability or on the frequency of the petite mutation. A detailed study of the PY-resistant mutants, and of mutants that can assimilate exogenous dTMP, should provide answers to these problems.
After this work was completed, a paper was published by Wintersberger & Hirsch (1973) in which they report that methotrexate at concentrations of I mM (432 pg/ml) and upwards can reduce the growth of some strains of' Saccharomyces cerevisiae and S. carl&sbcrgen.sis, and can induce the petite condition, when cslls are utilizing fermentable substrates.
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